Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Rivaroxaban (Atc Code According To Who: B01Af01)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 102078161

  Document Type - Tender Notices

Description - Description: The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 of the Social Code Book V for medicinal products containing the active ingredient rivaroxaban (ATC code ac cording to WHO: B01AF01), limited to film-coated tablets with an active strength of 2.5 mg. The contract is concluded within the framework of a so-called open house model, i.e. a contract is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. This means that individual contract negotiations are not conducted and there is no (supply) exclusivity. Please note

Gt Ref Id - 102078161

Deadline - May 31, 2025